As NTX acts as an antagonist to the μOR thus negating the inhibitory function of this opioid receptor on TRPM3, we tested whether the amplitudes of the PregS-induced currents were modified in NK cells treated with NTX from both HC and ME/CFS patients. The gene discussed is TRPM3; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.